AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation

Learning Objectives:

• List demographic factors that impact anti-COVID-19 antibody levels in convalescent plasma donors.
• Describe the qualities of antibody responses in blood donors who either had a prior COVID-19 infection or were vaccinated against COVID-19.
• List proteomic markers that improve engraftment potential of fetal liver-derived hematopoietic stem cells.
• Discuss steps that can be taken to improve survival of biotinylated red blood cells.

Moderator(s):

• Thomas Gniadek, MD, PHD, University of Chicago (NorthShore) Pathology
• Dr. Mary Berg, MD, Professor of Clinical Practice, Pathology Medical Director, Transfusion Services, University of Colorado

Speaker(s):

• Dr. Bryan R. Spencer, PhD, American Red Cross Scientific Affairs
• Kim Vanuytsel, Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center
• Amy Schmidt, MD, PhD, CSL
• Tamir Kanias, Vitalant Research Institute

Disclosures

• Kim Vanuytsel:
  Consultant: CSL Plasma
• Amy Schmidt, MD, PhD:
  Consultant: CSL Plasma
• Thomas Gniadek, MD, PHD:
  Consultant: Fresenius Kabi